David Dornan

Title: Innovations by David Dornan

Introduction

David Dornan is an accomplished inventor based in Redwood City, California. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic agents. With a total of two patents to his name, Dornan's work focuses on advancing medical treatments through novel binding agents.

Latest Patents

Dornan's latest patents include the development of Anti-Dectin-2 antibodies and methods of using them. This invention relates to dendritic cell-associated C-type lectin 2 (Dectin-2) binding agents, which are crucial for various medical applications. The patents encompass nucleic acids that comprise these inventive binding agents, as well as vectors and cells that utilize these nucleic acids. Furthermore, the invention outlines methods for providing these binding agents, treating diseases, disorders, or conditions in mammals, and stimulating antigen-presenting cells.

Career Highlights

David Dornan is currently associated with Bolt Biotherapeutics, Inc., where he continues to push the boundaries of biotherapeutic innovations. His work is instrumental in developing treatments that can significantly impact patient care and disease management.

Collaborations

Dornan collaborates with talented professionals in his field, including Shelley Erin Ackerman and Karla Ann Henning. These collaborations enhance the research and development efforts at Bolt Biotherapeutics, Inc.

Conclusion

David Dornan's contributions to biotechnology through his patents and work at Bolt Biotherapeutics, Inc. highlight his commitment to advancing medical science. His innovative approaches to treatment development are paving the way for future breakthroughs in healthcare.